(PharmaNewsWire.Com, September 28, 2017 ) An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as "Orphan Designations" by the regulatory agencies to accelerate the approval process.
Publisher's analysts forecast the global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.
Covered in this report The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.
Publisher's report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions - Americas - APAC - Europe
Key vendors - Bristol-Mayer Squibb - Celgene - F. Hoffmann La Roche - Novartis - Pfizer
Market driver - Shorter development timelines - For a full, detailed list, view our report
Market challenge - High cost of drug development - For a full, detailed list, view our report
Market trend - Increased focus on biological drugs - For a full, detailed list, view our report
Key questions answered in this report - What will the market size be in 2019 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors?
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
